Determination of Risk Factors and Mortality for Pediatric Chronic Critical Illness in Turkey

NCT03308513 | Completed

• 1 other identifier: Pediatric critical illness
• Study Type: observational
• Target: 888
• Locations: 1 country
• Sites: 1

Brief Summary

It is predicted that the number of Pediatric Chronic Critical Illness increases similar to adult all over the world. The prevalence of Pediatric Chronic Critical Illness in Turkey is unknown. The investigators aimed to evaluate the etiology, comorbid conditions, demographic data, prevalence, mortality and costs of these patient in intensive care units in Turkey. In this multi-centered study, The investigators will retrospectively review the last 3 year of patients receiving treatment at the Intensive Care Unit.

Conditions

Critical Illness

Keywords

Prolonged acute mechanical ventilation

Outcome Measures

Primary Outcomes (1)

• Critical care unit mortality

  The mortality change rates in the 30th Day, 90th Day, 180th Day, 365th Day

  30 Day, 90 Day, 180 Day, 365 day

Secondary Outcomes (2)

• Critical care unit costs for infant patients

  Duration of intensive care unit stay (From 14 day to 1 years after hospitalization)

• Critical care unit costs for premature newborn

  Duration of intensive care unit stay (From 1 month to 1 year after hospitalization)

Eligibility Criteria

• Age: Up to 18 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Probability Sample

Study Population

Patients who are younger than 18 years or are in intensive care unit

You may qualify if:

• Chronic Critical IIlness
• The patients who are younger than 18 years old and staying in ICU for at least 14 days.
• (The patients who is newborn and stay in the intensive care unit for 30 days in addition to prematurity).
• At least one of the additional criteria;
• Prolonged acute mechanical ventilation
• Tracheostomy
• Sepsis
• Severe wound (burn) or trauma
• Encephalopathy (Post resuscitation syndrome, Asphyxia, Intra-cranial hemorrhage, Metabolic disease, etc.)
• Traumatic brain injury
• Status epilepticus
• Post operative (Cardiac and noncardiac)
• Neuromuscular disease (Spinal Muscular Dystrophy, Cerebral Palsy, Muscular Dystrophy)

You may not qualify if:

• Patients with a disease other than a chronic critical disease
• Patients older than 18 years

Sponsors & Collaborators

• Yuzuncu Yil University: lead
• Kahramanmaras Sutcu Imam University: collaborator
• Izmir Ataturk Training and Research Hospital: collaborator

Study Sites (1)

Yuzuncu Yil University, School of Medicine

Van, Tusba / Zeve Kampus, 65080, Turkey (Türkiye)

Location

Related Publications (1)

• Demirkiran H, Kilic M, Tomak Y, Dalkiran T, Yurttutan S, Basaranoglu M, Tuncer O, Derme T, Tekeli AE, Bahar I, Keskin S, Oksuz H. Evaluation of the incidence, characteristics, and outcomes of pediatric chronic critical illness. PLoS One. 2021 May 28;16(5):e0248883. doi: 10.1371/journal.pone.0248883. eCollection 2021.

  PMID: 34048449 DERIVED

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Hilmi Demirkiran, Asist.prof.

  Department of Anethesiology and Reanimation

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Study Record Dates

• First Submitted: October 7, 2017
• First Posted: October 12, 2017
• Study Start: November 1, 2017
• Primary Completion: January 15, 2018
• Study Completion: October 31, 2018
• Last Updated: September 16, 2020

Record last verified: 2020-09

Locations

TU (1)